Pathology testing in Australia is big business, getting bigger as the population ages and we rely on high-tech medicine for intractable ailments. Advocacy by commercial interests and government pathology service providers shapes public policy. It potentially affects elections rather than just the national budget. It matters. It is inadequately recognised and less understood.
What we know about lobbying by the pathology industry in the 2016 election is how little we know. Our ignorance matters, because it tells us something about the realities of a liberal democracy in 2016. It also matters because we need an informed public discourse about health policy and health costs. (more…)
